Bone Biologics (BBLG) Other Operating Expenses (2010 - 2017)

Bone Biologics (BBLG) has 7 years of Other Operating Expenses data on file, last reported at -$3.5 million in Q2 2017.

• Other Operating Expenses for Q2 2017 came in at -$3.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was -$3.5 million (down 549.86% YoY), and the FY2017 annual result was -$2.7 million, down 56353.09% from the prior year.
• Other Operating Expenses declined to -$3.5 million in Q2 2017 per BBLG's latest filing, from $784525.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $877776.0 in Q3 2014 and troughed at -$3.5 million in Q2 2017.
• A 4-year average of -$149992.5 and a median of $1321.5 in 2013 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2013 and 2017: Other Operating Expenses sank 40.4% in 2013, then jumped 16235.85% in 2017.
• A 4-year view of Other Operating Expenses shows it stood at $668209.0 in 2013, then jumped by 31.36% to $877776.0 in 2014, then tumbled by 100.55% to -$4862.0 in 2016, then slumped by 72488.93% to -$3.5 million in 2017.
• Business Quant data shows BBLG's Other Operating Expenses at -$3.5 million in Q2 2017, $784525.0 in Q1 2017, and -$4862.0 in Q1 2016.